Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
450
NCT03797053
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology
Phase: N/A
Role: Collaborator
Start: Apr 6, 2015
Completion: Jun 30, 2019
NCT03507946
Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris
Role: Lead Sponsor
Start: Jan 31, 2023
Completion: Jun 30, 2024